A phase II, multicenter, open-label study evaluating dosing and preliminary safety and efficacy of canakinumab in systemic juvenile idiopathic arthritis with active systemic features期刊界 All Journals 搜尽天下杂志传播学术成果专业期刊搜索期刊信息化学术搜索

A phase II, multicenter, open-label study evaluating dosing and preliminary safety and efficacy of canakinumab in systemic juvenile idiopathic arthritis with active systemic features

Authors:	Ruperto Nicolino,Quartier Pierre,Wulffraat Nico,Woo Patricia,Ravelli Angelo,Mouy Richard,Bader-Meunier Brigitte,Vastert Sebastiaan J,Noseda Emanuele,D'Ambrosio Daniele,Lecot Jean,Chakraborty Abhijit,Martini Alberto,Chioato Andrea Paediatric Rheumatology International Clinical Trials Organisation

Affiliation:	IRCCS G. Gaslini, Genoa, Italy. nicolaruperto@ospedale-gaslini.ge.it

Abstract:

Keywords:
本文献已被 PubMed 等数据库收录！